Updates in Oncology Pharmacy: Lu-177

OncoPharm
26/01/2018 14 min
Updates in Oncology Pharmacy: Lu-177

Listen "Updates in Oncology Pharmacy: Lu-177"

Descargar episodio Ver en sitio original

Episode Synopsis

New Drug Approval: Lutetium-177-dotatate is discussed as well as updates to indications for denosumab (m. myeloma), afatinib, & olaparib.
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA